2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC2071
Submitter : Ms. Lori Mulvey Date & Time: 10/31/2005 06:10:58
Organization : Ms. Lori Mulvey
Category : Health Professional
Issue Areas/Comments
GENERAL
GENERAL
This correspondance is to oppose the constant delays in permitting EC to be sold over the counter without a prescription. Ec is most effective when taken within 24 hours and is perfectly safe for women of the United States to use when they deem necessary.